Fertility and Sterility
Volume 87, Issue 6 , Pages 1363-1368 , June 2007

Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome

  • Mithat Bahcecı, M.D.

      Affiliations

    • Department of Endocrinology and Metabolism, Dicle University School of Medicine, Diyarbakir
    • Corresponding Author InformationReprint requests: Mithat Bahcecı, M.D., Dicle University, School of Medicine, Department of Endocrinology and Metabolism, 21280 Diyarbakir, Turkey (FAX: +90 412 2488280).
    • ,
  • Mehmet Aydemır, M.D.

      Affiliations

    • Department of Internal Medicine, Mardin Government Hospital, Mardin, Turkey
    • ,
  • Alpaslan Tuzcu, M.D.

      Affiliations

    • Department of Endocrinology and Metabolism, Dicle University School of Medicine, Diyarbakir

Received 21 March 2006 ,Revised 20 October 2006 ,Accepted 10 November 2006.

References 

  1. Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:83–86
  2. Futterweit W, Mechanick JI. Polycystic ovarian disease: etiology, diagnosis, and treatment. Compr Ther. 1988;14:12–20
  3. Kelly CJ, Connell JM, Cameron IT, Gould GW, Lyall H. The long term health consequences of polycystic ovary syndrome. BJOG. 2000;107:1327–1338
  4. Bahceci M, Tuzcu A, Bahceci S, Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?. J Endocrinol Invest. 2003;26:655–659
  5. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tollerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165–169
  6. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin dependent diabetes mellitus. Am J Obstet Gynecol. 1995;98:33S–39S
  7. Bush TL, Fried LP, Barret-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem. 1988;34:B60–B70
  8. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Acta Obstet Gynaecol Scand. 1992;71:599–604
  9. Pyorola K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131–141
  10. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Clauda JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial and coronary heart disease mortality in a middle aged population. Diabetologica. 1980;19:205–210
  11. Zavaroni I, Bonora E, Pagliara M, Dall’Aglio E, Luchetti L, Buonanno G, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinaemia and normal glucose tolerance. N Engl J Med. 1989;320:702–706
  12. Bengtsson C, Bjorkelund C, Lapidus L, Lissner L. Association of serum lipid concentration and obesity with mortality in women (Twenty year follow up of participants in prospective population study in Gothenberg, Sweden). Br Med J. 1993;307:1385–1388
  13. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995;15:821–826
  14. Conway GS, Agrawal R, Betterridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;37:119–125
  15. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow up focussing on natural history and circulating hormones. Fertil Steril. 1992;57:505–513
  16. Blass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993;153:2209–2216
  17. Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf). 1996;44:277–284
  18. Velazquez ME, Bellabarba GA, Mendoza S, Sanchez L. Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin. Fertil Steril. 2000;74:1159–1163
  19. Homburg R. Polycystic ovary syndrome—from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod. 1996;11:29–39
  20. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447
  21. Rosen M, Cedars MI. Female reproductive endocrinology and infertility. In:  Greenspan FS,  Gardner DG editor. Basic and clinical endocrinology (A Lange medical book). 7th ed.. New York: McGraw-Hill; 2004;
  22. Tiret L, Gerdes C, Murphy MJ, Dallongeville J, Nicaud V, O’Reilly DS, et al. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease—the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest. 2000;30:578–585
  23. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM, et al. Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes. 2004;53:2353–2358
  24. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800
  25. Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ, et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis. 1995;113:273–287
  26. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Tsarpalis K, et al. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis. 2005;4:21
  27. Uiterwaal CS, Grobbee DE, Witteman JC, van Stiphout WA, Krauss XH, Havekes LM, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med. 1994;121:576–583
  28. Blackburn P, Cote M, Lamarche B, Couillard C, Pascot A, Tremblay A, et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism. 2003;52:1379–1386
  29. Ishikawa T. Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test. Nippon Rinsho. 1999;57:2668–2672

PII: S0015-0282(06)04513-4

doi: 10.1016/j.fertnstert.2006.11.031

Fertility and Sterility
Volume 87, Issue 6 , Pages 1363-1368 , June 2007

Article Tools